查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422777

全球穿戴式註射器市场：按类型、可用性、技术、治疗、最终用户、地区、机会、预测，2017-2031

Wearable Injectors Market Assessment, By Type, By Usability, By Technology, By Therapy, By End-User, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5个工作天内

价格
全球穿戴式註射器市场规模预计将从2023年的82.3亿美元成长到2031年的198亿美元，在2024-2031年的预测期内复合年增长率为11.6%。 全球可穿戴注射器市场的扩张是由给药系统的进步、需要持续用药的慢性病患病率上升、患者对自我给药的偏好增加以及长期给药需求的增加所推动的，包括可穿戴注射器的便利性。 此外，对家庭医疗保健的日益关注以及对微创给药方法的渴望进一步推动了全球穿戴式註射器市场的成长。

医疗保健工具的技术进步是全球穿戴式註射器市场大幅成长的关键驱动力。 穿戴式註射器设计的发展，包括更小的尺寸、更强的连接性和更高的可用性，正在改变药物输送方式，提高患者满意度和治疗依从性。 此外，需要定期注射的慢性疾病的增加也推动了全球穿戴式註射器市场的扩张。 糖尿病、自体免疫疾病和心血管疾病等疾病需要一致的剂量，这推动了对穿戴式註射器的需求。 这些设备提供了一种方便且易于管理的方法来提供处方治疗，使患者能够更有效地管理自己的健康。

此外，自我给药的趋势正在加速全球穿戴式註射器市场的发展。 穿戴式註射器使患者能够自主处理治疗，培养独立性并减少对医疗机构定期注射的需求。 这一趋势与以患者为中心的医疗保健的全面运动相一致，强调量身定制、可访问且有效的医疗解决方案。 此外，穿戴式註射器的剂量准确性和减少就诊次数的能力对市场扩张做出了重大贡献。 这些设备可确保准确输送剂量并提高治疗效果，同时减轻医疗保健系统的负担并减少患者因频繁就诊而造成的不便。

本报告调查了全球穿戴式註射器市场，并按类型、可用性、技术、治疗、最终用户、地区以及进入市场的公司概况提供了市场概述。

目录

第1章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章 2017-2031 年全球穿戴式註射器市场前景

  • 市场规模与预测
  • 依类型
  • 按可用性
  • 按技术
  • 依治疗方法
  • 按最终用户
  • 按地区
  • 各公司的市占率 (%)，2023 年

第 5 章 2017-2031 年全球穿戴式註射器市场前景（按地区）

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章市场地图，2023 年

第7章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

第 9 章监理架构与创新

第10章主要参会企业状况

第11章价格分析

第 12 章案例研究

第13章主要公司展望

  • Enable Injections, Inc.
  • SteadyMed Therapeutics, Inc.
  • Johnson & Johnson Services, Inc.
  • CeQur SA.
  • West Pharmaceutical Services, Inc.
  • Unilife Corporation
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Amgen, Inc.
  • Insulet Corporation

第 14 章策略建议

第15章查询及免责声明

Product Code: MX10975

Global wearable injectors market is projected to witness a CAGR of 11.6% during the forecast period 2024-2031, growing from USD 8.23 billion in 2023 to USD 19.8 billion in 2031. Numerous elements drive the expansion of the global wearable injectors market, including advancements in drug delivery systems, the escalating incidence of chronic illnesses needing ongoing medication heightened patient inclination toward self-administration, and the convenience of wearable injectors for prolonged drug delivery. Moreover, the increasing focus on home healthcare and the desire for less invasive drug delivery methods further propel the growth of the global wearable injectors market.

The substantial growth of the global wearable injectors market stems from a convergence of critical factors. Technological advancements in healthcare tools stand as a pivotal driver. Developments in wearable injector designs, including downsizing, connectivity enhancements, and improved user-friendliness, have transformed how drugs are administered, elevating patient satisfaction and adherence to treatments. Additionally, the rising occurrence of chronic illnesses requiring regular injections propels the expansion of the global wearable injectors market. Diseases like diabetes, autoimmune conditions, and cardiovascular disorders mandate consistent medication, spurring the demand for wearable injectors. These devices present a convenient, easily manageable approach to deliver prescribed therapies, empowering patients to take charge of their health more efficiently.

Moreover, the inclination towards self-administering medications amplifies the momentum of the global wearable injectors market. Wearable injectors empower patients to autonomously handle their treatments, fostering independence and reducing the need for healthcare facilities for routine injections. This trend aligns with the overarching movement towards patient-centered healthcare, emphasizing tailored, accessible, and effective medical solutions. Furthermore, the precision in dosing offered by wearable injectors and their ability to curtail hospital visits significantly contribute to market expansion. These devices ensure accurate delivery of dosages, improving treatment effectiveness, while easing the strain on healthcare systems and diminishing patient inconvenience associated with frequent clinic visits, which, in turn, is propelling the rapid growth of the global wearable injectors market.

Self-Administrative Drugs

The surge in demand for self-administered medications is a key catalyst propelling the global wearable injectors market expansion. This heightened need arises from several factors, notably the changing healthcare landscape where patients increasingly desire autonomy and convenience in managing their therapies. Empowering individuals through self-administration allows for greater control and flexibility in managing one's health. Furthermore, with the escalating prevalence of chronic diseases globally, there's a heightened necessity for continuous medication, driving the requirement for patient-centric drug delivery systems that are easy to use. Wearable injectors seamlessly integrate into this paradigm, providing a user-friendly interface for patients to self-administer medications. These devices boost patient adherence and cater to the growing preference for home-based healthcare solutions. The amalgamation of patient convenience, treatment control, and the simplicity of wearable injectors significantly fuels their adoption, fostering substantial growth in the global market.

Technological Advancements

Cutting-edge technologies, such as IQ (Intelligent Quality), are pivotal in driving the growth of the global wearable injectors market. By integrating intelligent features, IQ technology transforms drug delivery systems, guaranteeing precise dosing, heightened safety, and an improved user experience. These advancements not only enhance patient confidence but also promote adherence to treatments. IQ technology offers real-time monitoring, connectivity, and personalized dosing, which substantially advances wearable injector capabilities. Its integration effectively meets essential healthcare demands, fueling market expansion through the delivery of efficient, dependable, and patient-focused solutions.

The Tandem Mobi insulin delivery system, for example, was approved by the US Food and Drug Administration (FDA) in July 2023. Tandem Diabetes Care is a US-based diabetes technology firm. The device has been branded the "world's smallest insulin pump" by the manufacturer, and its full release is anticipated in the later parts of 2024. People with type 1 diabetes can employ Tandem Mobi's control-IQ technology, a hybrid-closed loop algorithm, starting at age six.

Government Initiatives

Governments globally are proactively launching programs and policies to improve the viability of injectors, stimulating the growth of the global wearable injectors market. These strategies span various actions, from funding research and development to facilitating innovative-friendly regulatory frameworks and implementing programs that enhance the accessibility and affordability of wearable injector technology. These collective endeavors create a favorable environment for incorporating these devices within healthcare systems. By strengthening feasibility and promoting widespread adoption, governmental initiatives play a substantial role in driving the rapid expansion of the global wearable injectors market.

For example, in July 2023, Bruce Fitch, the Health Minister, announced the expansion of insulin health programme to lower the cost of insulin pumps for Brunswick residents. Patients with type 1 diabetes who were above 25 years old could now use the gadget. The prevalence of diabetes is rising by 23% in New Brunswick. The announcement, which eliminates the age limit for insulin pumps, is a crucial component of a larger strategy for which the government has provided a sizeable amount of funds.

Growing Popularity of Insulin Patch

There's a notable rise in the global demand for insulin patches within the wearable injectors market. These patches offer a non-invasive, inconspicuous, and user-friendly approach to insulin delivery, catering to patients seeking alternatives to traditional injections. Their user convenience, combined with technological advancements, ensuring precise dosing and prolonged usage, strongly resonates with individuals managing diabetes. As diabetes rates escalate worldwide and there's an increased focus on improving patient experiences and adherence to treatments, insulin patches have emerged as a highly sought-after choice. Their appeal primarily lies in delivering continuous insulin without hassle, thereby fueling their increasing prominence in the global wearable injectors market.

For instance, in October 2023, Enable Injections, Inc. announced that the EMPAVELI Injector (enFuse) was approved by the U.S. Food and Drug Administration (FDA) for the subcutaneous delivery of EMPAVELI (pegcetacoplan), which is sold to adults with paroxysmal nocturnal hemoglobinuria (PNH) by Apellis Pharmaceuticals, Inc. in the United States. The EMPAVELI Injector is a wearable, small injector that is intended to simplify self-administration, while causing the least amount of disturbance to patients' everyday routines.

Wearable Injectors for Diabetes

Wearable injectors play a substantial role in the field of diabetes care, profoundly impacting the global market for such devices. These tools provide a convenient and user-friendly way to administer insulin, improving treatment adherence and patient comfort in diabetes management. Given the increasing global incidence of diabetes and the growing focus on personalized patient care, wearable injectors have become a favored insulin delivery method. Their precision in dosing, ease of use, and suitability for continuous therapies perfectly meets the needs of diabetes management, leading to their widespread adoption and driving the expansion.

For example, in November 2023, ViCentra launched a closed-loop diabetes solution in Europe by integrating an insulin pump with Dexcom and Diabeloop technology. The insulin pump is from ViCentra, the CGM is a Dexcom G6 sensor, and Diabeloop created the algorithm. In hybrid closed-loop systems, the output of an insulin pump is adjusted as needed during the day by use of an algorithm that first analyses real-time blood sugar readings from a continuous glucose monitor.

Future Market Scenario (2024-2031F)

The outlook for the global wearable injectors market is promising, driven by several pivotal factors. To begin, ongoing technological advancements continually enhance these devices, rendering them more user-friendly, precise, and adaptable to diverse therapeutic requirements. Secondly, the escalating incidence of chronic illnesses necessitating continuous treatment, coupled with the shift towards personalized healthcare, escalates the demand for wearable injectors. Furthermore, as healthcare systems worldwide prioritize cost-effectiveness and patient-centered care, these devices seamlessly cater to these objectives by offering convenience, bolstering treatment adherence and enabling remote monitoring. Moreover, the expansion of wearable injectors beyond conventional medications to encompass biologics and larger therapeutic molecules creates new opportunities for their utilization. Additionally, supportive governmental initiatives and increased investments in research and development (R&D) significantly contribute to the growth of the global wearable injectors market. This convergence of factors propels wearable injectors towards a promising future, set to revolutionize drug delivery and enhance global patient outcomes.

Key Players Landscape and Outlook

Major participants in the global wearable injectors market are actively engaging in mergers and acquisitions. These strategic endeavors focus on consolidating market presence, improving technological prowess and diversifying product arrays. Mergers allow firms to leverage synergies, merging skills and resources to pioneer and introduce cutting-edge solutions. Acquisitions provide entry into new markets, technologies, or intellectual property, fostering competitive edges. Such actions streamline operations, optimize distribution networks, and expedite market entry. Overall, these strategic initiatives among leading corporations signify a collective drive to fortify market standings, spur innovation, and address the evolving needs of consumers in the wearable injectors sector.

For example, in May 2023, the world-renowned healthcare technology giant Medtronic plc announced that it has signed a series of final agreements to buy EOFlow Co. Ltd., the company that makes the EOPatch, an insulin delivery device that is totally disposable, wearable, and tubeless. The integration of EOFlow with Medtronic's Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM) is anticipated to increase the company's capacity to cater to the requirements of a greater number of diabetes patients, irrespective of their insulin delivery preferences or treatment status.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Wearable Injectors Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Type
    • 4.2.1. Patch Pump/Injectors
    • 4.2.2. Infusion Pump/Injectors
  • 4.3. By Usability
    • 4.3.1. Disposable
    • 4.3.2. Reusable
  • 4.4. By Technology
    • 4.4.1. Motor Based
    • 4.4.2. Expanding Battery
    • 4.4.3. Rotary Pump
    • 4.4.4. Spring Based
    • 4.4.5. Others
  • 4.5. By Therapy
    • 4.5.1. Diabetes
    • 4.5.2. Autoimmune
    • 4.5.3. Cardiovascular
    • 4.5.4. Neurological
    • 4.5.5. Oncological
    • 4.5.6. Others
  • 4.6. By End-User
    • 4.6.1. Hospitals and Clinics
    • 4.6.2. Home Healthcare Setting
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. South America
    • 4.7.4. Asia-Pacific
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Wearable Injectors Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Type
      • 5.1.2.1. Patch Pump/Injectors
      • 5.1.2.2. Infusion Pump/Injectors
    • 5.1.3. By Usability
      • 5.1.3.1. Disposable
      • 5.1.3.2. Reusable
    • 5.1.4. By Technology
      • 5.1.4.1. Motor Based
      • 5.1.4.2. Expanding Battery
      • 5.1.4.3. Rotary Pump
      • 5.1.4.4. Spring Based
      • 5.1.4.5. Others
    • 5.1.5. By Therapy
      • 5.1.5.1. Diabetes
      • 5.1.5.2. Autoimmune
      • 5.1.5.3. Cardiovascular
      • 5.1.5.4. Neurological
      • 5.1.5.5. Oncological
      • 5.1.5.6. Others
    • 5.1.6. By End-User
      • 5.1.6.1. Hospitals and Clinics
      • 5.1.6.2. Home Healthcare Setting
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. Value
      • 5.1.7.1.2. Volume
      • 5.1.7.2. By Type
      • 5.1.7.2.1. Patch Pump/Injectors
      • 5.1.7.2.2. Infusion Pump/Injectors
      • 5.1.7.3. By Usability
      • 5.1.7.3.1. Disposable
      • 5.1.7.3.2. Reusable
      • 5.1.7.4. By Technology
      • 5.1.7.4.1. Motor Based
      • 5.1.7.4.2. Expanding Battery
      • 5.1.7.4.3. Rotary Pump
      • 5.1.7.4.4. Spring Based
      • 5.1.7.4.5. Others
      • 5.1.7.5. By Therapy
      • 5.1.7.5.1. Diabetes
      • 5.1.7.5.2. Autoimmune
      • 5.1.7.5.3. Cardiovascular
      • 5.1.7.5.4. Neurological
      • 5.1.7.5.5. Oncological
      • 5.1.7.5.6. Others
      • 5.1.7.6. By End-User
      • 5.1.7.6.1. Hospitals and Clinics
      • 5.1.7.6.2. Home Healthcare Setting
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Usability
  • 6.3. By Technology
  • 6.4. By Therapy
  • 6.5. By End-User
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Enable Injections, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. SteadyMed Therapeutics, Inc.
  • 13.3. Johnson & Johnson Services, Inc.
  • 13.4. CeQur SA.
  • 13.5. West Pharmaceutical Services, Inc.
  • 13.6. Unilife Corporation
  • 13.7. F. Hoffmann-La Roche Ltd.
  • 13.8. Becton, Dickinson and Company
  • 13.9. Amgen, Inc.
  • 13.10. Insulet Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 5. Global Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 6. Global Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 7. Global Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Wearable Injectors Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 11. North America Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 12. North America Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 13. North America Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 14. North America Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 15. North America Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Wearable Injectors Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 19. United States Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 20. United States Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 21. United States Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 22. United States Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 23. United States Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 26. Canada Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 27. Canada Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 28. Canada Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 29. Canada Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 30. Canada Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 33. Mexico Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 34. Mexico Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 35. Mexico Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 36. Mexico Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 37. Mexico Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 40. Europe Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 41. Europe Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 42. Europe Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 43. Europe Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 44. Europe Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Wearable Injectors Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 48. Germany Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 49. Germany Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 50. Germany Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 51. Germany Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 52. Germany Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 55. France Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 56. France Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 57. France Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 58. France Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 59. France Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 62. Italy Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 63. Italy Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 64. Italy Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 65. Italy Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 66. Italy Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 69. United Kingdom Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 70. United Kingdom Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 71. United Kingdom Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 72. United Kingdom Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 73. United Kingdom Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 76. Russia Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 77. Russia Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 78. Russia Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 79. Russia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 80. Russia Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 83. Netherlands Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 84. Netherlands Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 85. Netherlands Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 86. Netherlands Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 87. Netherlands Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Spain Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 91. Spain Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 92. Spain Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 93. Spain Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 94. Spain Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 97. Turkey Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 98. Turkey Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 99. Turkey Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 100. Turkey Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 101. Turkey Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 104. Poland Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 105. Poland Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 106. Poland Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 107. Poland Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 108. Poland Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 111. South America Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 112. South America Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 113. South America Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 114. South America Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 115. South America Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Wearable Injectors Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 119. Brazil Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 120. Brazil Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 121. Brazil Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 122. Brazil Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 123. Brazil Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 126. Argentina Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 127. Argentina Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 128. Argentina Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 129. Argentina Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 130. Argentina Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 133. Asia-Pacific Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 134. Asia-Pacific Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 135. Asia-Pacific Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 136. Asia-Pacific Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 137. Asia- Pacific Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Wearable Injectors Market Share (%), By Country, 2017-2031F
  • Figure 139. India Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 141. India Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 142. India Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 143. India Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 144. India Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 145. India Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 148. China Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 149. China Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 150. China Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 151. China Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 152. China Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 155. Japan Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 156. Japan Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 157. Japan Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 158. Japan Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 159. Japan Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 162. Australia Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 163. Australia Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 164. Australia Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 165. Australia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 166. Australia Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 169. Vietnam Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 170. Vietnam Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 171. Vietnam Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 172. Vietnam Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 173. Vietnam Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 176. South Korea Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 177. South Korea Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 178. South Korea Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 179. South Korea Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 180. South Korea Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 183. Indonesia Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 184. Indonesia Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 185. Indonesia Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 186. Indonesia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 187. Indonesia Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 190. Philippines Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 191. Philippines Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 192. Philippines Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 193. Philippines Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 194. Philippines Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 197. Middle East & Africa Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 198. Middle East & Africa Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 199. Middle East & Africa Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 200. Middle East & Africa Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 201. Middle East & Africa Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Wearable Injectors Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 205. Saudi Arabia Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 206. Saudi Arabia Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 207. Saudi Arabia Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 208. Saudi Arabia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 209. Saudi Arabia Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 212. UAE Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 213. UAE Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 214. UAE Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 215. UAE Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 216. UAE Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Wearable Injectors Market, By Volume, In Millions, 2017-2031F
  • Figure 219. South Africa Wearable Injectors Market Share (%), By Type, 2017-2031F
  • Figure 220. South Africa Wearable Injectors Market Share (%), By Usability, 2017-2031F
  • Figure 221. South Africa Wearable Injectors Market Share (%), By Technology, 2017-2031F
  • Figure 222. South Africa Wearable Injectors Market Share (%), By Therapy, 2017-2031F
  • Figure 223. South Africa Wearable Injectors Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Usability Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Therapy Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023